文献速递运动医学关节外科

多西环素促进大鼠前交叉韧带重建术后移植物愈合并减轻创伤后骨关节炎

Doxycycline Promotes Graft Healing and Attenuates Posttraumatic Osteoarthritis After Anterior Cruciate Ligament Reconstruction in a Rat Model.
PubMed 文献 · Am J Sports Med · 2023-01-16

在大鼠前交叉韧带重建模型中,口服多西环素(50 mg/kg/d)至处死可同步促进移植物愈合并减轻创伤后骨关节炎。第2周多西环素组移植物极限失败载荷(P=.002)和刚度(P=.007)显著更高;第6周改良Mankin评分更低(P=.033)、软骨表面MMP-13阳性软骨细胞更少(P=.002)、骨赘形成更少、步态更对称(P<.05),关节内MMP活性显著更低(P=.016)。

要点

  • 大鼠前交叉韧带重建后口服多西环素50 mg/kg/d可促进移植物愈合。
  • 多西环素组第2周移植物极限失败载荷和刚度显著高于对照组。
  • 多西环素组第6周改良Mankin评分更低、骨赘更少、步态更对称。

核心结论

  • 口服多西环素在大鼠前交叉韧带重建模型中能同步促进移植物愈合并减轻创伤后骨关节炎。

研究设计与样本

  • 控制性实验室研究,74只12-13周龄雄性Sprague Dawley大鼠行前交叉韧带重建,分为未治疗对照组和多西环素治疗组(50 mg/kg/d口服至处死)。

主要发现

  • 第2周多西环素组移植物极限失败载荷(P=.002)和刚度(P=.007)显著高于对照组。
  • 第6周多西环素组胫骨和股骨隧道的骨密度及骨体积/总体积均显著高于对照组(P<.05)。
  • 多西环素组总体移植物愈合评分显著更高,移植物-骨界面胶原1型和10型更多、MMP-13更少。
  • 第6周多西环素组改良Mankin评分更低(P=.033),关节软骨表面MMP-13阳性软骨细胞更少(P=.002)。
  • 第6周多西环素组骨赘形成更少、负重和步态更对称(P<.05),关节内MMP活性显著更低(P=.016)。

临床怎么用

  • 作者指出,多西环素是一种广泛使用的药物,可能对前交叉韧带重建术后患者有益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Doxycycline (Doxy) has been shown to facilitate tendon healing by reducing on-site matrix metalloproteinase (MMP) activity, but its effect on graft healing after anterior cruciate ligament reconstruction (ACLR) has not been investigated, and the therapeutic effect of Doxy in preventing ACLR-induced posttraumatic osteoarthritis (PTOA) is unclear. HYPOTHESIS: Doxy promotes graft healing and alleviates the progression of PTOA after ACLR. STUDY DESIGN: Controlled laboratory study. METHODS: Sprague Dawley rats (n = 74; age, 12-13 weeks; male) that underwent ACLR were divided into untreated control and Doxy treatment (50 mg/kg/d orally until sacrifice) groups. At 2 and 6 weeks after surgery, graft healing was assessed by biomechanical testing, histology, immunohistochemical staining, and micro-computed tomography (μCT). The progression of PTOA was evaluated at 6 weeks by histology, the Mankin score, and immunofluorescence staining of the tibial plateau, and osteophyte formation was evaluated by μCT. Hindlimb weight distribution was evaluated at 6 weeks, and gait patterns were evaluated at 2 and 6 weeks. Intra-articular MMP activity was evaluated at 6 weeks in vivo using an MMP-activatable near-infrared fluorescent probe. RESULTS: Graft healing was enhanced by Doxy treatment, and the ultimate failure load (P = .002) and stiffness of the graft (P = .007) were significantly higher in the Doxy group at week 2. Bone mineral density and bone volume/total volume for both the tibial and the femoral tunnels at week 6 in the Doxy group were significantly higher compared with in the control group (P < .05). The overall graft healing scores were significantly higher in the Doxy group. Doxy treatment enhanced graft integration, intratunnel graft integrity, and collagen birefringence; more collagen types 1 and 10 and less MMP-13 were found at the graft-bone interface. At week 6, the Doxy group had a lower modified Mankin score (P = .033) and showed fewer MMP 13-positive chondrocytes at the articular cartilage surface (P = .002), indicating moderate joint cartilage damage. μCT revealed less osteophyte formation, and gait analysis revealed more symmetric weightbearing and gait patterns, after Doxy treatment at week 6 (P < .05). In vivo imaging with the near-infrared fluorescent probe identified significantly lower intra-articular MMP activity in the Doxy group at week 6 (P = .016). CONCLUSION: The oral administration of Doxy was able to synchronously promote graft healing and attenuate PTOA in an ACLR rat model. CLINICAL RELEVANCE: Our results indicated that Doxy, a widely used drug, is potentially beneficial to patients after ACLR.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Cao M, Yao S, Zhu X, et al. Doxycycline Promotes Graft Healing and Attenuates Posttraumatic Osteoarthritis After Anterior Cruciate Ligament Reconstruction in a Rat Model. Am J Sports Med. 2023. PMID: 36645043. doi:10.1177/03635465221145015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。